HEADER ONCOPROTEIN/INHIBITOR 07-FEB-23 8G3E TITLE CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH (1M)-N-[(3,5- TITLE 2 DIFLUORO[1,1'-BIPHENYL]-4-YL)METHYL]-6-METHYL-4-OXO-1-(PYRIDIN-3-YL)- TITLE 3 1,4-DIHYDROPYRIDAZINE-3-CARBOXAMIDE (COMPOUND 2, WDR5-MYC INHIBITOR) COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WDR5, MYC, WBM, SMALL MOLECULE, ONCOPROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.ZHAO REVDAT 3 25-OCT-23 8G3E 1 REMARK REVDAT 2 05-JUL-23 8G3E 1 JRNL REVDAT 1 28-JUN-23 8G3E 0 JRNL AUTH J.DING,L.LIU,Y.L.CHIANG,M.ZHAO,H.LIU,F.YANG,L.SHEN,Y.LIN, JRNL AUTH 2 H.DENG,J.GAO,D.R.SAGE,L.WEST,L.A.LLAMAS,X.HAO,S.KAWATKAR, JRNL AUTH 3 E.LI,R.K.JAIN,J.A.TALLARICO,S.M.CANHAM,H.WANG JRNL TITL DISCOVERY AND STRUCTURE-BASED DESIGN OF INHIBITORS OF THE WD JRNL TITL 2 REPEAT-CONTAINING PROTEIN 5 (WDR5)-MYC INTERACTION. JRNL REF J.MED.CHEM. V. 66 8310 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37307526 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00787 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC V5.8.0253 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 126790 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.141 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.170 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6674 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4765 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09000 REMARK 3 B22 (A**2) : 0.59000 REMARK 3 B33 (A**2) : -0.59000 REMARK 3 B12 (A**2) : 0.26000 REMARK 3 B13 (A**2) : -0.14000 REMARK 3 B23 (A**2) : 0.10000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.051 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.049 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.040 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.318 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8G3E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272158. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-AUG-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 133465 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330 REMARK 200 RESOLUTION RANGE LOW (A) : 32.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 8F1G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23.5% PEG3350, 0.21 M AMMONIUM REMARK 280 SULFATE, 0.1 M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 19 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 PRO A 28 REMARK 465 THR A 29 REMARK 465 ASP A 211 REMARK 465 THR B 24 REMARK 465 GLN B 25 REMARK 465 SER B 26 REMARK 465 LYS B 27 REMARK 465 PRO B 28 REMARK 465 THR B 29 REMARK 465 ASP B 211 REMARK 465 ASP B 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 151 7.07 80.52 REMARK 500 LEU A 234 32.67 -82.63 REMARK 500 LYS A 259 -55.06 -129.25 REMARK 500 ASP A 324 -67.05 -126.43 REMARK 500 LYS B 67 7.76 81.14 REMARK 500 LEU B 234 32.85 -82.55 REMARK 500 LYS B 259 -55.45 -131.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 798 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH B 820 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH B 821 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH B 822 DISTANCE = 6.48 ANGSTROMS DBREF 8G3E A 22 334 UNP P61964 WDR5_HUMAN 22 334 DBREF 8G3E B 22 334 UNP P61964 WDR5_HUMAN 22 334 SEQADV 8G3E SER A 19 UNP P61964 EXPRESSION TAG SEQADV 8G3E ASN A 20 UNP P61964 EXPRESSION TAG SEQADV 8G3E ALA A 21 UNP P61964 EXPRESSION TAG SEQADV 8G3E SER B 19 UNP P61964 EXPRESSION TAG SEQADV 8G3E ASN B 20 UNP P61964 EXPRESSION TAG SEQADV 8G3E ALA B 21 UNP P61964 EXPRESSION TAG SEQRES 1 A 316 SER ASN ALA SER ALA THR GLN SER LYS PRO THR PRO VAL SEQRES 2 A 316 LYS PRO ASN TYR ALA LEU LYS PHE THR LEU ALA GLY HIS SEQRES 3 A 316 THR LYS ALA VAL SER SER VAL LYS PHE SER PRO ASN GLY SEQRES 4 A 316 GLU TRP LEU ALA SER SER SER ALA ASP LYS LEU ILE LYS SEQRES 5 A 316 ILE TRP GLY ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SEQRES 6 A 316 SER GLY HIS LYS LEU GLY ILE SER ASP VAL ALA TRP SER SEQRES 7 A 316 SER ASP SER ASN LEU LEU VAL SER ALA SER ASP ASP LYS SEQRES 8 A 316 THR LEU LYS ILE TRP ASP VAL SER SER GLY LYS CYS LEU SEQRES 9 A 316 LYS THR LEU LYS GLY HIS SER ASN TYR VAL PHE CYS CYS SEQRES 10 A 316 ASN PHE ASN PRO GLN SER ASN LEU ILE VAL SER GLY SER SEQRES 11 A 316 PHE ASP GLU SER VAL ARG ILE TRP ASP VAL LYS THR GLY SEQRES 12 A 316 LYS CYS LEU LYS THR LEU PRO ALA HIS SER ASP PRO VAL SEQRES 13 A 316 SER ALA VAL HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SEQRES 14 A 316 SER SER SER TYR ASP GLY LEU CYS ARG ILE TRP ASP THR SEQRES 15 A 316 ALA SER GLY GLN CYS LEU LYS THR LEU ILE ASP ASP ASP SEQRES 16 A 316 ASN PRO PRO VAL SER PHE VAL LYS PHE SER PRO ASN GLY SEQRES 17 A 316 LYS TYR ILE LEU ALA ALA THR LEU ASP ASN THR LEU LYS SEQRES 18 A 316 LEU TRP ASP TYR SER LYS GLY LYS CYS LEU LYS THR TYR SEQRES 19 A 316 THR GLY HIS LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN SEQRES 20 A 316 PHE SER VAL THR GLY GLY LYS TRP ILE VAL SER GLY SER SEQRES 21 A 316 GLU ASP ASN LEU VAL TYR ILE TRP ASN LEU GLN THR LYS SEQRES 22 A 316 GLU ILE VAL GLN LYS LEU GLN GLY HIS THR ASP VAL VAL SEQRES 23 A 316 ILE SER THR ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SEQRES 24 A 316 SER ALA ALA LEU GLU ASN ASP LYS THR ILE LYS LEU TRP SEQRES 25 A 316 LYS SER ASP CYS SEQRES 1 B 316 SER ASN ALA SER ALA THR GLN SER LYS PRO THR PRO VAL SEQRES 2 B 316 LYS PRO ASN TYR ALA LEU LYS PHE THR LEU ALA GLY HIS SEQRES 3 B 316 THR LYS ALA VAL SER SER VAL LYS PHE SER PRO ASN GLY SEQRES 4 B 316 GLU TRP LEU ALA SER SER SER ALA ASP LYS LEU ILE LYS SEQRES 5 B 316 ILE TRP GLY ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SEQRES 6 B 316 SER GLY HIS LYS LEU GLY ILE SER ASP VAL ALA TRP SER SEQRES 7 B 316 SER ASP SER ASN LEU LEU VAL SER ALA SER ASP ASP LYS SEQRES 8 B 316 THR LEU LYS ILE TRP ASP VAL SER SER GLY LYS CYS LEU SEQRES 9 B 316 LYS THR LEU LYS GLY HIS SER ASN TYR VAL PHE CYS CYS SEQRES 10 B 316 ASN PHE ASN PRO GLN SER ASN LEU ILE VAL SER GLY SER SEQRES 11 B 316 PHE ASP GLU SER VAL ARG ILE TRP ASP VAL LYS THR GLY SEQRES 12 B 316 LYS CYS LEU LYS THR LEU PRO ALA HIS SER ASP PRO VAL SEQRES 13 B 316 SER ALA VAL HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SEQRES 14 B 316 SER SER SER TYR ASP GLY LEU CYS ARG ILE TRP ASP THR SEQRES 15 B 316 ALA SER GLY GLN CYS LEU LYS THR LEU ILE ASP ASP ASP SEQRES 16 B 316 ASN PRO PRO VAL SER PHE VAL LYS PHE SER PRO ASN GLY SEQRES 17 B 316 LYS TYR ILE LEU ALA ALA THR LEU ASP ASN THR LEU LYS SEQRES 18 B 316 LEU TRP ASP TYR SER LYS GLY LYS CYS LEU LYS THR TYR SEQRES 19 B 316 THR GLY HIS LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN SEQRES 20 B 316 PHE SER VAL THR GLY GLY LYS TRP ILE VAL SER GLY SER SEQRES 21 B 316 GLU ASP ASN LEU VAL TYR ILE TRP ASN LEU GLN THR LYS SEQRES 22 B 316 GLU ILE VAL GLN LYS LEU GLN GLY HIS THR ASP VAL VAL SEQRES 23 B 316 ILE SER THR ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SEQRES 24 B 316 SER ALA ALA LEU GLU ASN ASP LYS THR ILE LYS LEU TRP SEQRES 25 B 316 LYS SER ASP CYS HET YJR A 401 32 HET YJR B 401 32 HETNAM YJR (1M)-N-[(3,5-DIFLUORO[1,1'-BIPHENYL]-4-YL)METHYL]-6- HETNAM 2 YJR METHYL-4-OXO-1-(PYRIDIN-3-YL)-1,4-DIHYDROPYRIDAZINE-3- HETNAM 3 YJR CARBOXAMIDE FORMUL 3 YJR 2(C24 H18 F2 N4 O2) FORMUL 5 HOH *620(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N SER A 318 O LYS A 328 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O ALA A 61 N LYS A 52 SHEET 3 AA2 4 ILE A 69 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 ILE A 83 -1 O ILE A 83 N ILE A 69 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O VAL A 103 N ALA A 94 SHEET 3 AA3 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 LYS A 120 LYS A 126 -1 O LEU A 125 N LEU A 111 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 LEU A 209 -1 O LEU A 209 N CYS A 195 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 ILE A 229 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LEU A 249 N LEU A 240 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O TRP A 273 N SER A 267 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 SHEET 1 AA8 4 ALA B 36 LEU B 41 0 SHEET 2 AA8 4 ILE B 327 LYS B 331 -1 O ILE B 327 N LEU B 41 SHEET 3 AA8 4 ILE B 315 ALA B 320 -1 N SER B 318 O LYS B 328 SHEET 4 AA8 4 VAL B 304 CYS B 309 -1 N ALA B 308 O ALA B 317 SHEET 1 AA9 4 VAL B 48 PHE B 53 0 SHEET 2 AA9 4 TRP B 59 SER B 64 -1 O ALA B 61 N LYS B 52 SHEET 3 AA9 4 LEU B 68 GLY B 73 -1 O TRP B 72 N LEU B 60 SHEET 4 AA9 4 PHE B 79 SER B 84 -1 O ILE B 83 N ILE B 69 SHEET 1 AB1 4 ILE B 90 TRP B 95 0 SHEET 2 AB1 4 LEU B 101 SER B 106 -1 O ALA B 105 N SER B 91 SHEET 3 AB1 4 THR B 110 ASP B 115 -1 O TRP B 114 N LEU B 102 SHEET 4 AB1 4 CYS B 121 LYS B 126 -1 O LEU B 122 N ILE B 113 SHEET 1 AB2 4 VAL B 132 PHE B 137 0 SHEET 2 AB2 4 LEU B 143 SER B 148 -1 O VAL B 145 N ASN B 136 SHEET 3 AB2 4 VAL B 153 ASP B 157 -1 O TRP B 156 N ILE B 144 SHEET 4 AB2 4 CYS B 163 LEU B 167 -1 O LEU B 167 N VAL B 153 SHEET 1 AB3 4 VAL B 174 PHE B 179 0 SHEET 2 AB3 4 LEU B 185 SER B 190 -1 O VAL B 187 N HIS B 178 SHEET 3 AB3 4 CYS B 195 ASP B 199 -1 O TRP B 198 N ILE B 186 SHEET 4 AB3 4 CYS B 205 LEU B 209 -1 O LEU B 206 N ILE B 197 SHEET 1 AB4 4 VAL B 217 PHE B 222 0 SHEET 2 AB4 4 TYR B 228 THR B 233 -1 O LEU B 230 N LYS B 221 SHEET 3 AB4 4 THR B 237 ASP B 242 -1 O TRP B 241 N ILE B 229 SHEET 4 AB4 4 LYS B 247 TYR B 252 -1 O LEU B 249 N LEU B 240 SHEET 1 AB5 4 ALA B 264 SER B 267 0 SHEET 2 AB5 4 TRP B 273 SER B 276 -1 O VAL B 275 N ASN B 265 SHEET 3 AB5 4 VAL B 283 ASN B 287 -1 O TYR B 284 N SER B 276 SHEET 4 AB5 4 ILE B 293 LEU B 297 -1 O LEU B 297 N VAL B 283 CRYST1 46.662 62.276 64.381 114.09 91.08 110.17 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021431 0.007873 0.004327 0.00000 SCALE2 0.000000 0.017107 0.008427 0.00000 SCALE3 0.000000 0.000000 0.017318 0.00000